Antisense compounds

Details for Australian Patent Application No. 2007310989 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Swayze, Eric E.

Agent Pizzeys

Pub. Number AU-A-2007310989

PCT Pub. Number WO2008/049085

Priority 60/852,894 18.10.06 US

Filing date 18 October 2007

Wipo publication date 24 April 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/712 (2006.01) - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose

Event Publications

21 May 2009 PCT application entered the National Phase

  PCT publication WO2008/049085 Priority application(s): WO2008/049085

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007310991-System for inducing desirable temperature effects on body tissue

2007310988-Tuned RF energy and electrical tissue characterization for selective treatment of target tissues